Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol for General Anaesthesia in TAVR
NCT05881291Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2023
- Primary completion
- Jul 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in aortic valve stenosis (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Area under the curve below baseline MAP. Started Jun 2023; status: completed.
02
Drugs
ciprofol
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT05881291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05881291.